Safety and outcome of direct retrograde cholangioscopy (DRC) using an ultra-Slim endoscope prototype and peroral cholangioscopy using a direct visualization system via the working channel of a duodenoscope

• Conditions: C22.1; C24.0; Intrahepatic bile duct carcinoma; Extrahepatic bile duct

• Registration Number: DRKS00015905
• Lead Sponsor: Robert Bosch Medizinische Forschung (RBMF) des Robert Bosch Krankenhaus Stuttgart

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-11-14
• Study Completion: 2021-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 73

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Complications after cholangioscopy defined as air embolism, cholangitis, pancreatitis, bleeding, hypoxia or malign arrhythmias

Secondary Outcome Measures

Name	Time	Method
1. technical evaluation regarding sight, advance, controallability, technical success<br>2. clinical success of an intended intervention (biopsy, ectomy, APC, laser, EHL)